An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

July 10, 2013

Primary Completion Date

December 2, 2015

Study Completion Date

December 2, 2015

Conditions
HepatitisHepatitis C
Interventions
DRUG

Algeron

1.5 µg/kg of body weight subcutaneously, once a week

DRUG

Pegasys

180 µg subcutaneously, once a week

Trial Locations (19)

10700

Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Bangkok

50200

Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai

127473

State Budgetary Higher Vocational Education Institution A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow

210037

Vitebsk Regional Clinical Hospital, Vitebsk

226003

M V Hospital & Research Center, Lucknow

246029

Gomel Regional Clinical Hospital, Homyel

400007

Bhatia Hospital, Medical Research Society Tardeo Road, Grant Road (W), Mumbai

411007

Medipoint Hospitals Pvt. Ltd., Pune

452001

Suyash Hospital Pvt. Ltd. Opposite M.G.M Medical College A.B. Road, Indore

Unknown

State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University, Moscow

"State Public Healthcare Institution of the City of Moscow Infectious Disease Clinical Hospital No. 1", Moscow

Federal State Budgetary Institution Research Institute of Influenza, Saint Petersburg

Federal State Military Higher Vocational Education Institution S.M. Kirov Military Medical Academy, Saint Petersburg

"LLC Medical Company Hepatolog", Samara

Municipal Healthcare Institution City Clinical Hospital No.2 named after V.I. Razumovsky, Saratov

Smolensk Regional Clinical Hospital, Smolensk

State Budgetary Higher Vocational Education Institution Smolensk State Medical Academy, Smolensk

State Budgetary Higher Vocational Education Institution Stavropol State Medical Academy, Stavropol

"State Medical and Preventive Institution of the Tyumen Region Advisory and Diagnostic Center", Tyumen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biocad

INDUSTRY

NCT01889433 - An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter